Skip to main content
Clinical Trials/NCT02915471
NCT02915471CompletedNot Applicable

Virtual Peer-to-peer (VP2P) Support Mentoring for Adolescents With Cancer: A Pilot Pragmatic Randomized Controlled Trial

The Hospital for Sick Children2 sites in 1 country37 target enrollmentStarted: August 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
37
Locations
2
Primary Endpoint
Accrual and Attrition rates

Study Overview

Brief Summary

The overall aim of this research program is to develop and examine the impact of a Cancer virtual peer-to-peer (VP2P) Support Program on health-related quality of life (HRQL) in adolescents with cancer (AWC). In the current proposal, the feasibility of trialing the Skype-based VP2P program providing peer-support from mentors and the magnitude of program effect estimates will be evaluated in a pilot randomized control trial (RCT). This pilot RCT will enable us to refine the program and determine the appropriate sample size for a future large-scale RCT, which will compare the effectiveness of VP2P to a waitlist control group at a major Children's Oncology Group- affiliated centers in Canada and the United States.

Detailed Description

The aim of this project is to develop and examine the impact of a virtual peer support program on health outcomes and quality of life of adolescents with cancer using a waitlist randomized controlled trial. In addition to standard medical care, adolescents in the experimental group will receive a manualized peer mentorship program that will provide modelling and reinforcement by trained young adults aged 18-25 years who have learned to function successfully with their pain. Mentoring sessions consist of 10 sessions of 30-45 minute Skype calls over 8 weeks. Feasibility of the program will be measured in addition to quality of life, physical and emotional symptoms, pain coping, self-efficacy, social support, and self-management skills.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
12 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • English-speaking 12-17 year olds
  • Cancer diagnosis with an expected 5-year survival rate of >70% according to treating oncologist (most childhood cancer diagnoses meet this criterion1)
  • Access to computer capable of using free Skype software (NB: 87% of American households had Internet access in)
  • Karnofsky or Lansky performance status of 60/100 (minimal assistance needed to complete activities) as assessed by the study coordinator at the time of recruitment. The Principal Investigator and Co-Investigators (Dr. Jennifer Stinson, Dr. Nathan and Dr. Gupta) will train the study coordinator to complete Karnofsky or Lansky performance assessments.
  • NB. Note that even though text messaging is part of the intervention, access to smartphones is not required. Smartphones (iPhone 6) may be loaned to participants by Dr. Stinson.

Exclusion Criteria

  • Significant cognitive impairment or major co-morbid illness as identified by their treating oncologist
  • Participation in other peer support or self-management programs
  • Receiving end-of-life care

Arms & Interventions

Virtual Peer-to-Peer Support Mentoring

Experimental

n addition to standard medical care, adolescents in the experimental group will receive the iP2P support program, a manualized peer-mentorship program that will provide mentoring and reinforcement by peers (young adults with cancer aged 16-25 years who have learned to function successfully with their cancer to the mentored participants).

Intervention: Virtual Peer-to-Peer Support Mentoring (Behavioral)

Wait-list Control

No Intervention

The control group will receive usual care but without the mentorship intervention. They will be offered the iP2P support program after completion of outcome measures (T1 - to be completed online prior to randomization; T2 - at program completion).

Outcomes

Primary Outcomes

Accrual and Attrition rates

Time Frame: 2 months

Technical difficulties - developed by the investigator

Time Frame: 2 months

Date, time and issue will be collected

Adherence

Time Frame: 2 months

100% if calls completed over 10 weeks

Proportion of completed questionnaires

Time Frame: 2 months

100% if all questions completed

Acceptability - semi structured interviews with AWC and mentors

Time Frame: 2 months

Semi-structured interviews will be developed by the investigator

Secondary Outcomes

  • Health Related Quality of Life (HRQL)(2 months)
  • Self-efficacy(2 months)
  • Transition readiness(2 months)
  • Perceived social support(2 months)
  • Knowledge(2 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jennifer Stinson

Clinician Scientist, Clinical Nurse Specialist/ NP

The Hospital for Sick Children

Study Sites (2)

Loading locations...

Similar Trials